Opportunity ID: 245353

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: RFA-AI-13-055
Funding Opportunity Title:: Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.855 — Allergy, Immunology and Transplantation Research
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 2
Posted Date:: Oct 24, 2013
Last Updated Date:: Nov 25, 2013
Original Closing Date for Applications:: Mar 07, 2014
Current Closing Date for Applications:: Jul 15, 2014
Archive Date:: Aug 15, 2014
Estimated Total Program Funding:: $ 4,000,000
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: This Funding Opportunity Announcement (FOA) solicits applications for support of pilot clinical trials to evaluate interventions aimed at the elimination of the HIV reservoir in HIV-infected adults who are on suppressive antiretroviral therapy. It is expected that the trials will be fully integrated with laboratory-based analytical tools to detect and measure elimination of latently-infected cells both in blood and in tissue.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 2 Modified Archive Date based on new Expiration Date, per NOT-AI-14-014. Nov 25, 2013
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Packages

Assistance Listings Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions Who Can Apply:
FORMS-C Forms-C PKG00187590 Feb 07, 2014 Jul 15, 2014 View eRA Commons Help Desk Organization Applicants